- 273 hospitals with the lowest readmission rates
- Holy Cross Health taps new COO from HCA hospital
- From Crisis Culture to Proactive, Strategic Operations
- 9 health systems on pharmacy, AI and OR strategy: 5 resources for healthcare leaders this week
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Hospital margins lag as expense growth outpaces inflation: 5 notes
- Every safety event has a cultural backstory – The hidden cost of dominant leadership in healthcare
- Franciscan Alliance CEO to retire
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Hiring, pay and restructuring: 4 HR leaders on difficult workforce decisions
- First free dental clinic opens in New Jersey
- The week in hospital M&A
- 5 dental insurance changes dentists need to know from the past 15 days
- A new medical school is opening nearby. What do health systems do first?
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- The ASC procedure list is growing — here’s what’s still missing
- wRVU pay, hospital subsidies don’t constitute Stark law fraud, court rules
- Specialty dentists’ compensation has climbed 39% since 2019
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- The case for layering behavioral healthcare models
- Why dentistry needs a revamp
- Rural, independent Kansas hospitals launch clinically integrated network
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- 7 DSOs making headlines
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Readers Curse Medical Debt and Defend Spelling Therapy
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
The decision on Smoke Away during the week of Canadian smoke... Someone has nice timing.
What do you think: was this false advertising?
The Federal Trade Commission took action under the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act (OARFPA), suing Michael J. Connors and companies he controls for deceptively marketing their Smoke Away products as able to eliminate consumers’ nicotine addiction and enable them to quit smoking quickly, easily, and permanently. The case is the FTC’s first smoking cessation product challenge under OARFPA, and its first alleging the deceptive use of testimonials to sell a supposed addition-treatment product.
The proposed stipulated order settling the Commission’s complaint permanently bans Connors - who settled a 2005 FTC complaint regarding Smoke Away - and his companies from marketing or selling any substance use disorder treatment product or service, including any smoking cessation product or service. The order also prohibits the defendants from making health-related advertising claims for other products unless they are substantiated by competent and reliable scientific evidence, prohibits them from using deceptive consumer testimonials, and imposes both a $7.1 million monetary judgment and a $500,000 civil penalty.
“Congress gave us strong tools to fight fraud targeting people suffering from addiction, and that is exactly what we are doing with this record-setting monetary judgment and industry ban,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Those struggling with alcohol, tobacco, or drugs deserve help and support, not phony promises, and we will continue to hold accountable those who prey on addiction sufferers.”
Smoke Away is the brand name for a line of supposed smoking cessation products, including Smoke Away Formula 1, Smoke Away Maintenance, Spray Away by Smoke Away, and Smoke Away Homeopathic Pellets. The complaint states that Connors has marketed Smoke Away through various corporate entities under his control, selling the product to consumers via the defendants’ own websites and online retailers, including Amazon, Walmart, and eBay. The products were sold individually and as “kits,” ranging from a “Basic Kit” for $69.95, up to “Premium Kit” that included homeopathic pellets for $89.95.
The defendants advertised their products as, “The Safe Way, The Smart Way, Smoke Away.” Their Amazon page said, “Attention all smokers. If you’re serious about kicking the habit, if you want to quickly and safely tackle your cravings for cigarettes, here is great news from the makers of Smoke Away. For less than the cost of gum, patches, or prescriptions that often don’t work, we’ll rush to you the all‑natural Smoke Away system that’s sweeping the country. … Don’t be a slave to cigarettes anymore. Quit Smoking for good. The safe way. The natural way. With the help of Smoke Away.”
The defendants advertised that Smoke Away Formula 1 would allow users to “[f]ight withdrawal symptoms naturally,” using “all-natural herbs … to help you stay calm and comfortable in spite of the nasty withdrawal symptoms your body throws at you.” Ads for Smoke Away Spray Away claimed that it “provides the convenience of a spray and the strength of the homeopathic medicine to help combat urges that arise. Whenever you feel one come on, simply spray 2 or 3 times under your tongue and the fast acting formula goes to work immediately.” According to the complaint, these and other claims regarding the efficacy for Smoke Away products were either false or not substantiated by competent and reliable scientific evidence.
Further, the complaint states that the company used consumer testimonials in which purported Smoke Away users, such as “Deborah from Conway, South Carolina,” said things like, “I just want to say I am so grateful for Smoke Away. It saved my life; it saved my friendships; it saved my wallet. … I decided when I saw it on the Internet, it looked very easy, it was guaranteed, and I thought what did I have to lose? … I, after a few days, did not even look for cigarettes or crave them. It’s been a month now, and since I’ve stopped smoking, my friends say my energy level is incredible. I look like a different person.”
According to the complaint, while the Smoke Away testimonialists claimed to be bona fide users of the product, some of them were actors whom the defendants hired and paid, and who had not used Smoke Away to quit smoking.
The FTC staff attorneys on this matter are Rafael Reyneri and Shira Modell.
The Commission voted 3-0 to refer the complaint and proposed stipulated federal order to the Department of Justice, with Chair Lina M. Khan issuing a separate statement. The DOJ filed the complaint and proposed order in the U.S. District Court for the Middle District of Florida.
The Federal Trade Commission works to promote competition and protect and educate consumers. Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov. Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















